EGLN2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases

• 收藏
• 分享

专利权人:

Sanofi-Aventis

发明人:

Herrmann, Matthias,Kozian, Detlef

申请号：

AU2006301579

公开号：

AU2006301579B2

申请日:

2006.09.30

申请国别(地区):

AU

年份:

2012

代理人:

摘要：

The invention relates to human EGLN2-variants having a serine or a leucine in position 58 of the amino acid sequence and to the use thereof in preventing or treating thromboembolic disorders or coronary heart diseases, in particular, cerebral apoplexy, prolonged reversible ischaemic neurological deficit (PRIND), transient ischaemic attack (TIA), myocardial infarct and/or premature myocardial infarct.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/